SETD2 and neoplasm: VHL is a tumor suppressor and is involved in the VHL-HIF pathway, its loss leading to an overexpression of HIF1 and HIF2, which also leads to VEGF overexpression triggering events such as proliferation, apoptosis and angiogenesis.